x
Filter:
Filters applied
- Clinical Practice Guidelines and Recommendations
- LetterRemove Letter filter
Clinical Practice Guidelines and Recommendations
4 Results
- Letter to the Editor
Accumulated Short Bouts of Physical Activity Are Associated With Reduced Premature All-Cause Mortality: Implications for Physician Promotion of Physical Activity and Revision of Current US Government Physical Activity Guidelines
Mayo Clinic ProceedingsVol. 90Issue 8p1168–1169Published in issue: August, 2015- Paul D. Loprinzi
Cited in Scopus: 15Current physical activity (PA) guidelines issued by the US Department of Health and Human Services recommend that adults engage in 150 min/wk or more of moderate to vigorous PA (MVPA). Stated in the guidelines, this dose of MVPA is to occur in bouts lasting at least 10 minutes; thus, a brisk 6-minute MVPA walk from the car to the office would not count toward the 150 min/wk goal. - Letter to the Editor
In reply–Clinical Practice Guidelines: Still Miles to Go…
Mayo Clinic ProceedingsVol. 89Issue 6p860–861Published in issue: June, 2014- Joseph D. Feuerstein
- Daniel A. Leffler
- Adam S. Cheifetz
Cited in Scopus: 0We thank Khan et al for their interest in our article assessing practice guidelines in interventional medical specialties1 and strongly agree that the issues with guidelines go beyond just those of the interventional subspecialties. In fact, we have already reported the results of other studies citing the limited evidence among gastroenterology2 and inflammatory bowel disease3 guidelines, and others have shown similar results for cardiology,4 infectious diseases,5 and liver diseases.6 - Letter to the Editor
Clinical Practice Guidelines: Still Miles to Go…
Mayo Clinic ProceedingsVol. 89Issue 6p859–860Published in issue: June, 2014- Abdur Rahman Khan
- Faraz Khan Luni
- George Victor Moukarbel
Cited in Scopus: 0In their article published in the January 2014 issue of Mayo Clinic Proceedings, Feuerstein et al1 reported that only a relatively small number of the guidelines from interventional subspecialty societies are based on evidence derived from randomized controlled trials. This scenario is not limited to guidelines developed by interventional medicine societies; guidelines developed by other professional organizations are also largely based on low levels of evidence.2-4 This factor is largely related to lack of research focused toward bridging gaps in the evidence base. - Letters
Dosage Guidelines for Pediatric Hypertension
Mayo Clinic ProceedingsVol. 70Issue 4p406Published in issue: April, 1995- Bruce Z. Morgenstern
Cited in Scopus: 0The comprehensive review of the clinical aspects of pediatric hypertension by Lieberman in the November 1994 issue of the Mayo Clinic Proceedings (pages 1098 to 1107) contains some dosage guidelines for medications used in the treatment of hypertensive emergencies that bear analysis, specifically those for diazoxide and labetalol hydrochloride. The risks associated with bolus diazoxide therapy have been well described.1 The efficacy of “minibolus” doses (1 to 3 mg/kg) was first demonstrated in 1979,2 although the use of smaller doses in children was described by Boerth and Long in 1977.
